MEDP

NASD Medpace Holdings, Inc.
Oct 2, 2026 · 4:09 AM ET EOD Market Closed

$598.08 ↑ +0.00 (+0.00%) Trading Up from the previous close of $598.08, $30.52 below the day’s high of $628.60

YTD change
+6.49%
vs 20-day SMA
-1.62%
vs 200-day SMA
+14.27%

Price ranges

Previous day
$597.37 $628.60
open $626.88 close $598.08
-$28.80 (-4.59%)
Today
$597.37 $628.60
$598.08
Past week
$608.05 $628.69
from $617.15 now $598.08
-$19.07 (-3.09%)
Past month
$577.64 $637.65
from $583.21 now $598.08
+$14.87 (+2.55%)
This year
$373.00 $677.90
from $561.65 now $598.08
+$36.43 (+6.49%)

Price & Performance

+99.74 (+20.01%) / 6M

$374.48$466.03$557.58$649.13Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 11.8% away from all-time highs of $677.90
  • MEDP is up 6% since the beginning of the year
  • MEDP is up 10% over the past 12 months
  • MEDP is up 3% over the past 1 month
  • 7% of all MEDP investors are betting against MEDP

MEDP reads not so good: price sits above one of the two key moving averages, the 12-month move is +11.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $4.25
Earnings momentum +3.8% Quarterly EPS growth
Quarterly change +3.8%

Valuation

P/E ratio 36.53
Enterprise value $17.5B
Beta 0.84

Balance sheet & scale

Income$491.5K
Revenue$2.8B
Cash$502.7M
Debt$144.1K
Income / Debt 3.41×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $16.7B

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: North America, Europe, Asia, South America, Africa and Australia. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.